Clindamycin Phosphate Gel
Product Images NDC 73473-302

2 FDA label images from Solaris Pharma Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clindamycin Phosphate (NDC 73473-302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solaris Pharma Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Clindamycin Phosphate Gel Chemical Structure)

Structure (Clindamycin Phosphate Gel Chemical Structure)
Chemical structure diagram representing the active ingredient clindamycin phosphate, showing its molecular arrangement including functional groups and bonded atoms.*
FDA Label Image

Carton (Clindamycin Phosphate Gel Carton 75ml)

Carton (Clindamycin Phosphate Gel Carton 75ml)
Packaging label for Clindamycin Phosphate Gel USP 1%, a topical gel formulation supplied in a 75 mL container. The label displays the Solaris Pharma logo and includes directions for use, storage instructions, and ingredient information. It is indicated for prescription use only and manufactured by Solaris Pharma Corporation, Bridgewater, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.